Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 1789

1.

Single-nucleotide polymorphisms of the adherent junction component cadherin gene are associated with leukoaraiosis.

Yadav BK, Shin BS.

Gene. 2018 Nov 15;676:65-72. doi: 10.1016/j.gene.2018.07.007. Epub 2018 Jul 12.

PMID:
30017735
2.

MicroRNA-219-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Regulating Cadherin 1.

Yang J, Sheng YY, Wei JW, Gao XM, Zhu Y, Jia HL, Dong QZ, Qin LX.

Biomed Res Int. 2018 May 15;2018:4793971. doi: 10.1155/2018/4793971. eCollection 2018.

3.

Spatial and temporal organization of cadherin in punctate adherens junctions.

Indra I, Choi J, Chen CS, Troyanovsky RB, Shapiro L, Honig B, Troyanovsky SM.

Proc Natl Acad Sci U S A. 2018 May 8;115(19):E4406-E4415. doi: 10.1073/pnas.1720826115. Epub 2018 Apr 24.

4.

Expression of E-cadherin in lung carcinoma, other than those with small cells (NSCLC).

Grigoraş ML, Arghirescu TS, Folescu R, Talpoş IC, Gîndac CM, Zamfir CL, Cornianu M, Anghel MD, Levai CM.

Rom J Morphol Embryol. 2017;58(4):1317-1325.

5.

Plasma sE-cadherin and the plasma sE-cadherin/sVE-cadherin ratio are potential biomarkers for chronic obstructive pulmonary disease.

Shirahata T, Nakamura H, Nakajima T, Nakamura M, Chubachi S, Yoshida S, Tsuduki K, Mashimo S, Takahashi S, Minematsu N, Tateno H, Asano K, Fujishima S, Betsuyaku T.

Biomarkers. 2018 Jul;23(5):414-421. doi: 10.1080/1354750X.2018.1434682. Epub 2018 Feb 12.

PMID:
29376431
6.

Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors.

Busch EL, Don PK, Chu H, Richardson DB, Keku TO, Eberhard DA, Avery CL, Sandler RS.

BMC Cancer. 2018 Jan 16;18(1):82. doi: 10.1186/s12885-017-3964-3.

7.

CDH1 promoter methylation in patients with cervical carcinoma: a systematic meta-analysis with trial sequential analysis.

Liu G.

Future Oncol. 2018 Jan;14(1):51-63. doi: 10.2217/fon-2017-0267. Epub 2017 Dec 14.

PMID:
29237293
8.

Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.

Melo S, Figueiredo J, Fernandes MS, Gonçalves M, Morais-de-Sá E, Sanches JM, Seruca R.

Int J Mol Sci. 2017 Dec 12;18(12). pii: E2687. doi: 10.3390/ijms18122687. Review.

9.

Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.

Xia L, Hu Y, Gu T, Wang L, Tian Z.

Int J Oncol. 2018 Feb;52(2):496-504. doi: 10.3892/ijo.2017.4210. Epub 2017 Nov 22.

PMID:
29207084
10.

Clinical and biological significance of a - 73A > C variation in the CDH1 promoter of patients with sporadic gastric carcinoma.

Zhang B, Zhou J, Liu Z, Gu L, Ji J, Kim WH, Deng D.

Gastric Cancer. 2018 Jul;21(4):606-616. doi: 10.1007/s10120-017-0778-6. Epub 2017 Nov 22.

PMID:
29168119
11.

Loss of E-cadherin provides tolerance to centrosome amplification in epithelial cancer cells.

Rhys AD, Monteiro P, Smith C, Vaghela M, Arnandis T, Kato T, Leitinger B, Sahai E, McAinsh A, Charras G, Godinho SA.

J Cell Biol. 2018 Jan 2;217(1):195-209. doi: 10.1083/jcb.201704102. Epub 2017 Nov 13.

12.

Influence of autocrine growth hormone on NF-κB activation leading to epithelial-mesenchymal transition of mammary carcinoma.

Baskari S, Govatati S, Madhuri V, Nallabelli N, K PM, Naik S, Poornachandar, Balka S, Tamanam RR, Devi VR.

Tumour Biol. 2017 Oct;39(10):1010428317719121. doi: 10.1177/1010428317719121.

PMID:
29022487
13.

E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.

Rosso M, Majem B, Devis L, Lapyckyj L, Besso MJ, Llauradó M, Abascal MF, Matos ML, Lanau L, Castellví J, Sánchez JL, Pérez Benavente A, Gil-Moreno A, Reventós J, Santamaria Margalef A, Rigau M, Vazquez-Levin MH.

PLoS One. 2017 Sep 21;12(9):e0184439. doi: 10.1371/journal.pone.0184439. eCollection 2017.

14.

Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.

Chandolia B, Rajliwal JP, Bajpai M, Arora M.

J Coll Physicians Surg Pak. 2017 Aug;27(8):475-478. doi: 2673.

PMID:
28903838
15.

Expression and potential roles of sodium-potassium ATPase and E-cadherin in human gastric adenocarcinoma.

Wang SH, Wang KL, Yang WK, Lee TH, Lo WY, Lee JD.

PLoS One. 2017 Aug 23;12(8):e0183692. doi: 10.1371/journal.pone.0183692. eCollection 2017.

16.

MicroRNA-720 Regulates E-cadherin-αE-catenin Complex and Promotes Renal Cell Carcinoma.

Bhat NS, Colden M, Dar AA, Saini S, Arora P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S, Dahiya R.

Mol Cancer Ther. 2017 Dec;16(12):2840-2848. doi: 10.1158/1535-7163.MCT-17-0400. Epub 2017 Aug 11.

PMID:
28802251
17.

E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis.

Liu JB, Feng CY, Deng M, Ge DF, Liu DC, Mi JQ, Feng XS.

World J Surg Oncol. 2017 Aug 1;15(1):139. doi: 10.1186/s12957-017-1210-8.

18.

Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.

Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW.

Breast Cancer Res. 2017 Jul 27;19(1):86. doi: 10.1186/s13058-017-0880-z.

19.

Reduced expression of E-cadherin and increased sialylation level in clear cell renal cell carcinoma.

Borzym-Kluczyk M, Radziejewska I, Cechowska-Pasko M, Darewicz B.

Acta Biochim Pol. 2017;64(3):465-470. doi: 10.18388/abp.2015_1215. Epub 2017 Jul 24.

20.

E-cadherin expression increases cell proliferation by regulating energy metabolism through nuclear factor-κB in AGS cells.

Park SY, Shin JH, Kee SH.

Cancer Sci. 2017 Sep;108(9):1769-1777. doi: 10.1111/cas.13321. Epub 2017 Aug 11.

Supplemental Content

Support Center